APA (7th ed.) Citation

Corrado, A., Aceto, R., Silvestri, R., Dell'Anno, I., Ricci, B., Miglietta, S., . . . Gemignani, F. (2021). Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System. Thyroid, 31(7), 1056. https://doi.org/10.1089/thy.2020.0366

Chicago Style (17th ed.) Citation

Corrado, Alda, et al. "Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System." Thyroid 31, no. 7 (2021): 1056. https://doi.org/10.1089/thy.2020.0366.

MLA (9th ed.) Citation

Corrado, Alda, et al. "Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System." Thyroid, vol. 31, no. 7, 2021, p. 1056, https://doi.org/10.1089/thy.2020.0366.